113 related articles for article (PubMed ID: 9873474)
1. Actinomycin D, C2 and VII, inhibitors of Grb2-SHC interaction produced by Streptomyces.
Nam JY; Kim HK; Son KH; Kim SU; Kwon BM; Han MY; Chung YJ; Bok SH
Bioorg Med Chem Lett; 1998 Aug; 8(15):2001-2. PubMed ID: 9873474
[TBL] [Abstract][Full Text] [Related]
2. Natural and synthetic analogues of actinomycin D as Grb2-SH2 domain blockers.
Kim HK; Nam JY; Han MY; Son KH; Choi JD; Kwon BM; Takusagawa HL; Huang Y; Takusagawa F
Bioorg Med Chem Lett; 2000 Jul; 10(13):1455-7. PubMed ID: 10888331
[TBL] [Abstract][Full Text] [Related]
3. Actinomycin D as a novel SH2 domain ligand inhibits Shc/Grb2 interaction in B104-1-1 (neu*-transformed NIH3T3) and SAA (hEGFR-overexpressed NIH3T3) cells.
Kim HK; Nam JY; Han MY; Lee EK; Choi JD; Bok SH; Kwon BM
FEBS Lett; 1999 Jun; 453(1-2):174-8. PubMed ID: 10403397
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Shc/Grb2 protein-protein interaction suppresses growth of B104-1-1 tumors xenografted in nude mice.
Kim HK; Jeong MJ; Kong MY; Han MY; Son KH; Kim HM; Hong SH; Kwon BM
Life Sci; 2005 Dec; 78(3):321-8. PubMed ID: 16146636
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
6. Novel peptide inhibitors for Grb2 SH2 domain and their detection by surface plasmon resonance.
Lung FD; Tsai JY; Wei SY; Cheng JW; Chen C; Li P; Roller PP
J Pept Res; 2002 Sep; 60(3):143-9. PubMed ID: 12213123
[TBL] [Abstract][Full Text] [Related]
7. Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain.
de Mol NJ; Catalina MI; Fischer MJ; Broutin I; Maier CS; Heck AJ
Biochim Biophys Acta; 2004 Jul; 1700(1):53-64. PubMed ID: 15210125
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2.
McNemar C; Snow ME; Windsor WT; Prongay A; Mui P; Zhang R; Durkin J; Le HV; Weber PC
Biochemistry; 1997 Aug; 36(33):10006-14. PubMed ID: 9254595
[TBL] [Abstract][Full Text] [Related]
10. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain.
Rojas M; Yao S; Donahue JP; Lin YZ
Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774
[TBL] [Abstract][Full Text] [Related]
11. 8-O-Methylsclerotiorinamine, antagonist of the Grb2-SH2 domain, isolated from Penicillium multicolor.
Nam JY; Kim HK; Kwon JY; Han MY; Son KH; Lee UC; Choi JD; Kwon BM
J Nat Prod; 2000 Sep; 63(9):1303-5. PubMed ID: 11000046
[TBL] [Abstract][Full Text] [Related]
12. Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domain.
Liu WQ; Vidal M; Gresh N; Roques BP; Garbay C
J Med Chem; 1999 Sep; 42(18):3737-41. PubMed ID: 10479306
[TBL] [Abstract][Full Text] [Related]
13. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs.
Liu WQ; Vidal M; Olszowy C; Million E; Lenoir C; Dhôtel H; Garbay C
J Med Chem; 2004 Feb; 47(5):1223-33. PubMed ID: 14971902
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the SH2 domain of Grb2/Ash complexed with EGF receptor-derived phosphotyrosine-containing peptide.
Tsuchiya S; Ogura K; Hatanaka H; Nagata K; Terasawa H; Mandiyan V; Schlessinger J; Aimoto S; Ohta H; Inagaki F
J Biochem; 1999 Jun; 125(6):1151-9. PubMed ID: 10348919
[TBL] [Abstract][Full Text] [Related]
18. Potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics.
Li P; Zhang M; Long YQ; Peach ML; Liu H; Yang D; Nicklaus M; Roller PP
Bioorg Med Chem Lett; 2003 Jul; 13(13):2173-7. PubMed ID: 12798329
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 1.
Furet P; Caravatti G; Denholm AA; Faessler A; Fretz H; García-Echeverría C; Gay B; Irving E; Press NJ; Rahuel J; Schoepfer J; Walker CV
Bioorg Med Chem Lett; 2000 Oct; 10(20):2337-41. PubMed ID: 11055351
[TBL] [Abstract][Full Text] [Related]
20. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain.
Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW
Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
